0001628280-23-025009.txt : 20230717 0001628280-23-025009.hdr.sgml : 20230717 20230717172021 ACCESSION NUMBER: 0001628280-23-025009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230713 FILED AS OF DATE: 20230717 DATE AS OF CHANGE: 20230717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patience David CENTRAL INDEX KEY: 0001970009 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31822 FILM NUMBER: 231092381 MAIL ADDRESS: STREET 1: C/O ACCELERATE DIAGNOSTICS, INC. STREET 2: 3950 S. COUNTRY CLUB ROAD, SUITE 240 CITY: TUCSON STATE: AZ ZIP: 85714 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Accelerate Diagnostics, Inc CENTRAL INDEX KEY: 0000727207 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 841072256 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 BUSINESS PHONE: 303-863-8088 MAIL ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 FORMER COMPANY: FORMER CONFORMED NAME: ACCELR8 TECHNOLOGY CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: HYDRO SEEK INC DATE OF NAME CHANGE: 19880802 4 1 wk-form4_1689628810.xml FORM 4 X0508 4 2023-07-13 0 0000727207 Accelerate Diagnostics, Inc AXDX 0001970009 Patience David C/O ACCELERATE DIAGNOSTICS, INC. 3950 S. COUNTRY CLUB ROAD, SUITE 470 TUCSON AZ 85714 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-07-13 4 M 0 330 0 A 7849 D Common Stock 2023-07-13 4 S 0 92 6.90 D 7757 D Common Stock 760 I By Spouse IRA Employee Restricted Stock Units 2023-07-13 4 M 0 330 0 D Common Stock 330 1655 D The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. On July 11, 2023, the issuer effected a reverse stock split of its common stock at a ratio of 1-for-10 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, proportionate adjustments were made to the number of shares of the issuer's common stock underlying its outstanding equity awards, warrants and convertible notes, as well as the exercise or conversion price, as applicable. The amounts reported herein (and to be reported in subsequent reports) have been adjusted to reflect the Reverse Stock Split. /s/ David Patience 2023-07-17